Abbott Pays $385M to Resolve 2022 Baby Formula Crisis

Abbott Laboratories will pay $385 million to settle claims from the contamination investigation that shut down America's largest baby formula plant and sparked nationwide shortages in 2022.

The resolution brings accountability to a crisis that left countless parents scrambling to feed their babies.